Cubist Systematic Strategies’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Cubist Systematic Strategies’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18,846	Closed	-$738K	–	2512
2018 Q4	$738K	Buy	18,846 +13,375	+244%	+$580K	0.03%	718
2018 Q3	$298K	Buy	5,471 +2,228	+69%	+$152K	0.02%	1166
2018 Q2	$268K	Buy	+3,243	New	+$250K	0.01%	1166
2017 Q4	–	Sell	-8,588	Closed	-$766K	–	2201
2017 Q3	$766K	Buy	8,588 +6,187	+258%	+$470K	0.04%	562
2017 Q2	$143K	Buy	+2,401	New	+$134K	0.01%	1382
2016 Q2	–	Sell	-10,157	Closed	-$300K	–	1972
2016 Q1	$300K	Buy	10,157 +936	+10%	+$29.5K	0.02%	984
2015 Q4	$418K	Buy	9,221 +1,224	+15%	+$64.2K	0.02%	919
2015 Q3	$334K	Buy	+7,997	New	+$417K	0.02%	1182
2015 Q2	–	Sell	-4,111	Closed	-$319K	–	2163
2015 Q1	$319K	Buy	+4,111	New	+$237K	0.02%	1219

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Cubist Systematic Strategies's ONCE Position: Q1 2019 in Review

Cubist Systematic Strategies sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 18,846 shares — an estimated $738K sold.

Cubist Systematic Strategies first reported a position in ONCE in Q1 2015 and held it in 9 quarters. The position peaked at $766K in Q3 2017. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

Cubist Systematic Strategies reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Cubist Systematic Strategies sold 18,846 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $738K.
Cubist Systematic Strategies first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
Cubist Systematic Strategies's Spark Therapeutics, Inc. Common Stock position peaked at $766K in Q3 2017.
199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Cubist Systematic Strategies's 13F filing for Q1 2019, filed 15 May 2019.